Machine Learning in Cardio-Oncology: New Insights from an Emerging Discipline

• Published in: Reviews in cardiovascular medicine 2023-10, Vol.24 (10), p.296
• Main Authors: Zheng, Yi, Chen, Ziliang, Huang, Shan, Zhang, Nan, Wang, Yueying, Hong, Shenda, Chan, Jeffrey Shi Kai, Chen, Kang-Yin, Xia, Yunlong, Zhang, Yuhui, Lip, Gregory Y H, Qin, Juan, Tse, Gary, Liu, Tong
• Format: Article
• Language: English
• Subjects: cardio-oncology; cardiotoxicity; inequity; machine learning; multidisciplinary team; Review
• ISSN: 1530-6550; 2153-8174; 1530-6550
• DOI: 10.31083/j.rcm2410296

A growing body of evidence on a wide spectrum of adverse cardiac events following oncologic therapies has led to the emergence of cardio-oncology as an increasingly relevant interdisciplinary specialty. This also calls for better risk-stratification for patients undergoing cancer treatment. Machine learning (ML), a popular branch discipline of artificial intelligence that tackles complex big data problems by identifying interaction patterns among variables, has seen increasing usage in cardio-oncology studies for risk stratification. The objective of this comprehensive review is to outline the application of ML approaches in cardio-oncology, including deep learning, artificial neural networks, random forest and summarize the cardiotoxicity identified by ML. The current literature shows that ML has been applied for the prediction, diagnosis and treatment of cardiotoxicity in cancer patients. In addition, role of ML in gender and racial disparities for cardiac outcomes and potential future directions of cardio-oncology are discussed. It is essential to establish dedicated multidisciplinary teams in the hospital and educate medical professionals to become familiar and proficient in ML in the future.